Literature DB >> 8128574

Field efficacy of injectable moxidectin in cattle naturally infested with Chorioptes bovis and Sarcoptes scabiei.

B Losson1, J F Lonneux.   

Abstract

Field efficacy of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis and Sarcoptes scabiei. Eight animals were allocated to two groups of four animals each, based on parasitological and clinical status. Animals of the treated group received one subcutaneous injection of injectable moxidectin at 0.2 mg kg-1 body weight on Day 0. Individuals of the control group received emergency treatment of a single injection of moxidectin at 0.2 mg kg-1 body weight on Day 28. Efficacy was assessed by (a) taking skin samples from each animal on Days 0, 7, 14, 21, 28, 42 and 56 and observing the numbers of viable mite stages and species and (b) clinical examination of animals on Days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated for each animal on Days 0, 28 and 56. On the basis of the geometric means from treated and control animals, the percentage reductions in the total numbers of living C. bovis mites on Days 7, 14, 21 and 28 were 69, 87, more than 99 and 98, respectively. However, at the end of the trial, only two animals were negative for C. bovis. The percentage reductions in the total numbers of S. scabiei on Days 7, 14, 21 and 28 were 93, 100, 100 and 100, respectively. Clinical indices of the treated animals showed a sharp decrease in the affected body surface area from a mean of 43.6% on Day 0 to 0.9% and 0% on Days 28 and 56, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8128574     DOI: 10.1016/0304-4017(93)90202-x

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  6 in total

1.  Comparative therapeutic effect of moxidectin, doramectin and ivermectin on psoroptes mites infestation in buffalo (Bubalus bubalis).

Authors:  Sabry A el-Khodery; Mitsu Ishii; Salama A Osman; Magdy H Al-Gaabary
Journal:  Trop Anim Health Prod       Date:  2009-04-04       Impact factor: 1.559

2.  In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei.

Authors:  Kate E Mounsey; Shelley F Walton; Ashlee Innes; Skye Cash-Deans; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  Efficacy of ivermectin and moxidectin injection against larvae of Wohlfahrtia magnifica (Diptera: Sarcophagidae) in sheep.

Authors:  R Farkas; M J Hall; M Dániel; L Börzsönyi
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

4.  Moxidectin efficacy in a goat herd with chronic and generalized sarcoptic mange.

Authors:  Nektarios D Giadinis; Rania Farmaki; Nikolaos Papaioannou; Elias Papadopoulos; Harilaos Karatzias; Alexander F Koutinas
Journal:  Vet Med Int       Date:  2011-05-19

5.  Prospects for Moxidectin as a New Oral Treatment for Human Scabies.

Authors:  Kate E Mounsey; Charlotte Bernigaud; Olivier Chosidow; James S McCarthy
Journal:  PLoS Negl Trop Dis       Date:  2016-03-17

6.  Drug dose and animal welfare: important considerations in the treatment of wildlife.

Authors:  Kate Mounsey; Robert J Harvey; Victoria Wilkinson; Kotaro Takano; Julie Old; Hayley Stannard; Leanne Wicker; David Phalen; Scott Carver
Journal:  Parasitol Res       Date:  2022-02-11       Impact factor: 2.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.